Zobrazeno 1 - 10
of 346
pro vyhledávání: '"Gramolelli S"'
Autor:
Alve S; Translational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Gramolelli S; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Jukonen J; Translational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Juteau S; Department of Pathology, Helsinki University Hospital (HUS), University of Helsinki, Helsinki, Finland., Pink A; Translational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Manninen AA; Department of Plastic Surgery, Park Hospital, Helsinki University Hospital (HUS), and., Hänninen S; Department of Pathology, Helsinki University Hospital (HUS), University of Helsinki, Helsinki, Finland., Monto E; Translational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Lackman MH; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Carpén O; Helsinki Biobank, and.; Department of Pathology and Research Program in Systems Oncology, University of Helsinki, HUS Diagnostic Center, Helsinki University Hospital, Finland., Saharinen P; Translational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Wihuri Research Institute, Biomedicum, Helsinki, Finland.; Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Karaman S; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Wihuri Research Institute, Biomedicum, Helsinki, Finland., Vaahtomeri K; Translational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Wihuri Research Institute, Biomedicum, Helsinki, Finland., Ojala PM; Translational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Pathology, Helsinki University Hospital (HUS), University of Helsinki, Helsinki, Finland.
Publikováno v:
JCI insight [JCI Insight] 2024 Jan 09; Vol. 9 (1). Date of Electronic Publication: 2024 Jan 09.
The anaphase promoting complex or cyclosome (APC/C) is a large E3 ubiquitin ligase, composed of 14 subunits. The activity of APC/C oscillates during the cell cycle to ensure a timely transition through each phase by promoting the degradation of impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::cb80ef02f9d4d0914daa1ba36923cd5f
http://hdl.handle.net/10044/1/78164
http://hdl.handle.net/10044/1/78164
Autor:
Alve S; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Gramolelli S; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Ojala PM; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. paivi.ojala@helsinki.fi.; Section of Virology, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK. paivi.ojala@helsinki.fi.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2265, pp. 141-154.
Autor:
Gramolelli, S., Weidner-Glunde, M., Abere, B., Viejo-Borbolla, A., Bala, K., Rückert, J., Kremmer, E., Schulz, T.F.
Publikováno v:
PLoS Pathog. 11:e1005105 (2015)
Kaposi's sarcoma (KS), caused by Kaposi's sarcoma herpesvirus (KSHV), is a highly vascularised tumour of endothelial origin. KSHV infected endothelial cells show increased invasiveness and angiogenesis. Here, we report that the KSHV K15 protein, whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3474::f44fc1fbbf1745b4ada8dcad453943f8
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=46610
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=46610
Autor:
Elbasani E; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland., Falasco F; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland., Gramolelli S; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland., Nurminen V; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland., Günther T; Heinrich Pette Institute, Leibniz Institute for Experimental Virology, 20251 Hamburg, Germany., Weltner J; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland., Balboa D; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland., Grundhoff A; Heinrich Pette Institute, Leibniz Institute for Experimental Virology, 20251 Hamburg, Germany., Otonkoski T; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland., Ojala PM; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.; Department of Infectious Diseases, Imperial College London, London W2 1NY, UK.
Publikováno v:
Viruses [Viruses] 2020 Aug 27; Vol. 12 (9). Date of Electronic Publication: 2020 Aug 27.
Autor:
Gramolelli S; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Elbasani E; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Tuohinto K; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Nurminen V; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Günther T; Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany., Kallinen RE; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Kaijalainen SP; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Diaz R; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Grundhoff A; Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany., Haglund C; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Ziegelbauer JM; HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Pellinen T; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Bower M; National Centre for HIV Malignancy, Chelsea & Westminster Hospital, London, United Kingdom., Francois M; The David Richmond Program for Cardio-Vascular Research: Gene Regulation and Editing, The Centenary Institute, The University of Sydney, Camperdown, Australia., Ojala PM; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. p.ojala@imperial.ac.uk.; Department of Infectious Diseases, Imperial College London, Medical School Building, St. Mary's Campus, London, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2020 Aug 01; Vol. 80 (15), pp. 3116-3129. Date of Electronic Publication: 2020 Jun 09.
Autor:
Elbasani E; Translational Cancer Medicine Research Program, University of Helsinki, Helsinki, Finland., Gramolelli S; Translational Cancer Medicine Research Program, University of Helsinki, Helsinki, Finland., Günther T; Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany., Gabaev I; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom., Grundhoff A; Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany., Ojala PM; Translational Cancer Medicine Research Program, University of Helsinki, Helsinki, Finland paivi.ojala@helsinki.fi.; Department of Infectious Diseases, Imperial College London, London, United Kingdom.
Publikováno v:
Journal of virology [J Virol] 2020 Jun 16; Vol. 94 (13). Date of Electronic Publication: 2020 Jun 16 (Print Publication: 2020).
Autor:
Choi, Kyoung-Min1 (AUTHOR), Kim, Sung-Jin1 (AUTHOR), Ji, Mi-Jung2 (AUTHOR), Kim, Eunjung3 (AUTHOR), Kim, Jae-Sung4 (AUTHOR), Park, Hyun‑Mee2 (AUTHOR), Kim, Jae-Young1 (AUTHOR) jaeyoungkim@cnu.ac.kr
Publikováno v:
Cell Communication & Signaling. 8/14/2024, Vol. 22 Issue 1, p1-15. 15p.
Autor:
Romano, Rita, Tabacchi, F., Russo, Gianluca, Gramolelli, S., Verzaro, Simona, Marinucci, Francesco, Paganotti, G. M., Gaeta, Aurelia, COLUZZI BARTOCCIONI, Caio Mario
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3686::44e835e3c1b56ec656bd4c13799cef55
http://hdl.handle.net/11573/404771
http://hdl.handle.net/11573/404771